News | News By Subject | News by Disease News By Date | Search News

Discontinued News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Juno (JUNO) Finally Drops Problem CAR-T Drug That Caused Deaths     3/3/2017
Top 7 Jaw-Dropping Pipeline Blowups This Year     12/5/2016
SoCal's Arrowhead Pharma (ARWR) Stock Craters After Terminating 30% of Workforce, Discontinuing Work on Lead Hep B Drugs     12/1/2016
Pfizer (PFE) Abandons Cholesterol Drug Bococizumab, Writes it Off as an Earnings Loss     11/3/2016
In 3Q Report, Shire (SHPG) Breaks Out Data From Baxalta (BXLT) Acquisition and Announces Several Program Terminations     11/2/2016
Biogen (BIIB) Quietly Kills Autoimmune Program     10/28/2016
23andMe Kills Its Next Generation Gene Sequencing Project, Cuts Jobs     10/27/2016
Shkreli Called it: Mast Therapeutics (MSTX) Begins Winding Down Vepoloxamer Programs     9/26/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug     9/23/2016
Struggling AVEO Oncology (AVEO) Quietly Discontinues Phase II Ficlatuzumab Study     9/13/2016
Merck & Co. (MRK) Terminates Development of Osteoporosis Drug Due to Stroke Risk     9/2/2016
Shire (SHPG) Kills Baxalta (BXLT)'s Hemophilia B Program; Clears Path for BioMarin (BMRN), Spark Therapeutics (ONCE) and uniQure (QURE)     8/4/2016
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank     7/26/2016
Citius Pharma Discontinues Development of Weight Loss Drug Suprenza     7/5/2016
UK Drugs Regulator Halts Approvals for Quest Life Sciences     7/1/2016

Featured Stories
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine     5/5/2011
Life Science Weekly inSite (Sep. 29 - Oct. 3)     10/6/2008
Most Failed Clinical Trials Are Never Published     9/23/2008
Unfavorable Drug Studies Don't Get Into Print: Report     1/17/2008
Discontinued Drug Helps Ulcerative Colitis     12/20/2007
U.S. Seizes Discontinued Eyelash Product, Harm Vision     11/19/2007
Merck & Co., Inc. (MRK) Tells AIDS Vaccine Volunteers Who Got Jab     11/14/2007
Cancelled Merck & Co., Inc. (MRK) Vaccine May Have Boosted HIV Risk     11/8/2007
Bay Area Firms Bridge 'Valley of Death'     8/20/2007
Biotech Day In Review: Novartis International AG (NVS) Pulls Zelnorm Off The Market     4/2/2007
FDA Halts Sales Of Some Quinine Drugs     12/13/2006
FDA Halts Unapproved Antihistamines     6/8/2006
Vioxx Heart Risk Found To Be Early And Persistent     5/4/2006
NEJM: Pactimibe Does Not Stop Plaque Formation     3/23/2006
NeuroDerm (NDRM) to Discontinue ND0612H Phase III, Suspend iNDiGO After FDA Meeting     12/5/2016
GI Dynamics (GID.AX) Discontinues U.S. Trial of EndoBarrier Therapy     7/30/2015
Alkermes plc (ALKS) Discontinues Development of Pain Drug     2/24/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Reports Top-Line Data For Phase 2 Study Of KB001-A To Treat Pseudomonas Aeruginosa Lung Infections In Cystic Fibrosis Patients     1/7/2015
Roche (RHHBY) Provides Update On Gantenerumab Development Programme     12/19/2014
Genentech (RHHBY) Informs Customers of Important Information About Triad Group's Alcohol Prep Pads     1/14/2011
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials     7/23/2008
Gene-testing Firms Under Fire     6/16/2008
Alkermes (ALKS) Provides Update on Inhaled Insulin Program; Eli Lilly and Company (LLY) Expected to Discontinue the Program     3/7/2008
AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets     12/28/2007
Hospira, Inc. (HSP) Discontinues 5% Alcohol in 5% Dextrose Injection Drug Product     12/28/2007
GeoVax Labs Inc. (GOVX.OB) Comments on Discontinuance of Merck & Co., Inc. (MRK)'s HIV Vaccine Trial     9/24/2007
AmerisourceBergen (ABC) Receives DEA Order to Temporarily Halt Distribution of Controlled Substances from Its Orlando, Florida Facility     4/25/2007
Sosei Inc. To Discontinue AD 452 Phase IIb Clinical Trial     11/21/2006
Inhibitex, Inc. (INHX) Provides Update On Status Of Veronate(R) Program     4/28/2006

More News
No News Posted on that date

Career Tips
How This Senior Scientist Got A Job At StemBioSys     3/28/2017
What 5 Different Pharma Marketing Careers Look Like     3/28/2017
5 Mistakes To Avoid When Talking To A Life Science Job Recruiter     3/28/2017
Things To Factor In When Deciding To Do A Postdoc In Academia Or Industry     3/28/2017
How To Get A Product Manager Gig In Biotech     3/25/2017
How To Rework Your Resume To Make The Big Data Leap From Tech To Biotech     3/23/2017
Scientists: 7 Ways How to Avoid Biotech Employers That Are Likely to Go Financially Bust     3/17/2017
True or False: Publishing Negative Results Ruins Your Science Career     3/16/2017
A Day In The Life Of A Scientist At AstraZeneca     3/16/2017
A New Career For Scientists: Science Communication     3/16/2017
In Between Jobs? Become A Lab Rat For Science     3/16/2017
Why These 3 Reasons Can Make You Stay Or Leave Your Life Science Job     3/16/2017
The Secret Lives Of Scientists     3/16/2017
Scientists, Here’s the Best Elevator Pitch to Sell Yourself to a Potential Employer     3/3/2017
This Technical Skill Wanted for Cancer Research Jobs     3/3/2017

Other News Sources
//-->